Brainstorm Cell Therapeutics (BCLI) Q2 2026 Earnings

18MayConfirmed
Q3 2025
Q4 2025
Q4 2025
Next
-0.39
-0.32
-0.26
-0.19

Details

Expected EPS
-0.36
Actual EPS
N/A
Surprise EPS
0.36
Surprise Percent
+100%

Description

Brainstorm Cell Therapeutics (BCLI) will report earnings of for Q2 2026 on May 18, 2026.

0 Comments

Share your thoughts